Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis.

about

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis.

Item

http://www.wikidata.org/entity/Q47367539

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@en

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@nl

type

Item

label

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@en

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@nl

prefLabel

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@en

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@nl

P1476

Ficoll-hypaque separation vs w ...... mal residual disease analysis.

@en

P2093

A Gazzola

http://www.w3.org/2001/XMLSchema#string

B Mantoan

http://www.w3.org/2001/XMLSchema#string

C Mannu

http://www.w3.org/2001/XMLSchema#string

D Barbero

http://www.w3.org/2001/XMLSchema#string

E Ciabatti

http://www.w3.org/2001/XMLSchema#string

Fondazione Italiana Linfomi (FIL) MRD Network

http://www.w3.org/2001/XMLSchema#string

I Del Giudice

http://www.w3.org/2001/XMLSchema#string

I Della Starza

http://www.w3.org/2001/XMLSchema#string

I Dogliotti

http://www.w3.org/2001/XMLSchema#string

L A De Novi

http://www.w3.org/2001/XMLSchema#string

P2860

IMGT, the international ImMunoGeneTics information system

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnostics

Assuring the quality of next-generation sequencing in clinical laboratory practice.

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.

Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms.

MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.

P304

201-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12766

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29205868

http://www.w3.org/2001/XMLSchema#string